"2022 年肿瘤生物治疗前沿热点研讨会"纪要.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 502, doi. 10.3872/j.issn.1007-385x.2022.05.017
- By:
- Publication type:
- Article
Works matching IS 1007385X AND DT 2022 AND VI 29 AND IP 5
Results: 17
1
2
CXCL1 在肿瘤发生发展中作用的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 497, doi. 10.3872/j.issn.1007-385x.2022.05.016
- By:
- Publication type:
- Article
3
评估免疫检查点抑制剂治疗非小细胞肺癌预后的生物标志物.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 489, doi. 10.3872/j.issn.1007-385x.2022.05.015
- By:
- Publication type:
- Article
4
PARP抑制剂治疗转移性去势抵抗性前列腺癌的机制及其临床研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 483, doi. 10.3872/j.issn.1007-385x.2022.05.014
- By:
- Publication type:
- Article
5
醛缩酶家族在恶性肿瘤中作用的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 478, doi. 10.3872/j.issn.1007-385x.2022.05.013
- By:
- Publication type:
- Article
6
免疫细胞单细胞测序对肿瘤免疫治疗疗效预测的意义.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 472, doi. 10.3872/j.issn.1007-385x.2022.05.012
- By:
- Publication type:
- Article
7
纳武单抗联合伊匹单抗对比纳武单抗单用方案治疗恶性肿瘤有效性和 安全性的Meta分析
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 464, doi. 10.3872/j.issn.1007-385x.2022.05.011
- By:
- Publication type:
- Article
8
基于列线图探索脑内皮黏附分子表达水平在结肠癌预后预测中的作用.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 456, doi. 10.3872/j.issn.1007-385x.2022.05.010
- By:
- Publication type:
- Article
9
lncRNA ZFAS1 通过miR-588/HMGA2 轴促进肝癌HepG2 细胞的增殖、 侵袭和迁移.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 449, doi. 10.3872/j.issn.1007-385x.2022.05.009
- By:
- Publication type:
- Article
10
ITGB2 在肾细胞癌组织中的表达及其对ACHN细胞恶性生物学行为的 影响.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 442, doi. 10.3872/j.issn.1007-385x.2022.05.008
- By:
- Publication type:
- Article
11
lncRNATUG1 通过miR-524-5p/BRAF轴调节甲状腺乳头状癌TPC-1 细 胞的增殖、凋亡和EMT进程.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 434, doi. 10.3872/j.issn.1007-385x.2022.05.007
- By:
- Publication type:
- Article
12
铁死亡在结直肠癌再生细胞放疗抵抗中的作用及其可能的机制.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 426, doi. 10.3872/j.issn.1007-385x.2022.05.006
- By:
- Publication type:
- Article
13
新型全人源LAG3 单克隆抗体的体外抗肿瘤作用及其机制初探.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 419, doi. 10.3872/j.issn.1007-385x.2022.05.005
- By:
- Publication type:
- Article
14
PARP1 通过调控N-糖基转移酶FUT8 影响胃癌AGS细胞的增殖与5-FU 耐药.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 410, doi. 10.3872/j.issn.1007-385x.2022.05.004
- By:
- Publication type:
- Article
15
EBV阳性鼻咽癌相关性中性粒细胞抑制肿瘤微环境中的CD8+ T细胞活化.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 399, doi. 10.3872/j.issn.1007-385x.2022.05.003
- By:
- Publication type:
- Article
16
新型纳米递送系统在药物诱导肿瘤细胞焦亡中的应用.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 391, doi. 10.3872/j.issn.1007-385x.2022.05.002
- By:
- Publication type:
- Article
17
基于HLA-E功能特点的肿瘤免疫治疗新策略.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 5, p. 383, doi. 10.3872/j.issn.1007-385x.2022.05.001
- By:
- Publication type:
- Article